Tech Center 1600 • Art Units: 1636
This examiner grants 59% of resolved cases
Khaleda B Hasan is an examiner in Tech Center 1600, assigned to Art Unit 1636. She has resolved 133 cases, and her allowance rate is 59.4 percent. This provides an outlook for applicants, with more than half of the cases reaching allowance. The data offers a baseline for practitioners to manage their expectations when their application is assigned to her. The 133 resolved cases provide the context for these metrics.
The interview lift of 49.5 percent is a significant figure in Hasan's profile. This indicates that interviews are effective at moving cases toward a grant compared to the 59.4 percent baseline. Practitioners should consider an interview as a tactic to resolve rejections. The median time to allowance is 1257 days, which is a timeframe for successful prosecution in Art Unit 1636. The 49.5 percent lift suggests that this time could be utilized in direct dialogue.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19630254 | Compositions and Methods Comprising a TTR Guide RNA and a Polynucleotide Encoding an RNA-Guided DNA Binding Agent | Non-Final OA | Intellia Therapeutics, Inc. |
| 17735929 | Methods and Compositions for Directed Genome Editing | Non-Final OA | Intellia Therapeutics, Inc. |
| 17559926 | MAMMALIAN CELL LINES WITH SIRT-1 GENE KNOCKOUT | Final Rejection | Hoffmann-La Roche Inc. |
| 18057359 | EXOSOMES COMPRISING THERAPEUTIC POLYPEPTIDES | Non-Final OA | Oxford University Innovation Limited |
| 17906372 | METHODS AND COMPOSITIONS FOR IMPROVED TYPE I-E CRISPR BASED GENE SILENCING | Non-Final OA | Duke University |
| 16547019 | METHODS FOR DELIVERING GENE EDITING REAGENTS TO CELLS WITHIN ORGANS | Final Rejection | BLUEALLELE, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy